Advertisement

MMW - Fortschritte der Medizin

, Volume 160, Issue 18, pp 60–65 | Cite as

Darüber sollten Sie Ihre Patienten informieren

Typ-2-Diabetes: Remission is possible!

  • Johannes SchollEmail author
FORTBILDUNG . ÜBERSICHT

Aktuelle Studien haben gezeigt, dass bei mehr als der Hälfte der neu entdeckten Diabetesfälle eine Remission innerhalb weniger Wochen möglich ist. Deshalb fordert der Autor: Jeder Typ-2-Diabetiker sollte darüber informiert werden, dass sich sein Diabetes zurückbilden kann.

Remission is possible. Every patient with type 2 diabetes should have the right to reverse his diabetes!

Keywords

Type 2 diabetes remission meal replacement therapy very low-carb ketogenic diet DIRECT VIRTA Health 

Literatur

  1. 1.
    Harcombe, Z., J.S. Baker, and B. Davies, Evidence from prospective cohort studies does not support current dietary fat guidelines: a systematic review and meta-analysis. Br J Sports Med, 2017. 51 (24): p. 1743-1749.Google Scholar
  2. 2.
    Harcombe, Z., J.S. Baker, and B. Davies, Evidence from prospective cohort studies did not support the introduction of dietary fat guidelines in 1977 and 1983: a systematic review. Br J Sports Med, 2017. 51(24): p. 1737–1742.CrossRefGoogle Scholar
  3. 3.
    Kuhn, J.P., et al., Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging. Radiology, 2017. 284(3): p. 706–716.CrossRefGoogle Scholar
  4. 4.
    Astley, C.M., et al., Genetic Evidence That Carbohydrate-Stimulated Insulin Secretion Leads to Obesity. Clinical Chemistry, 2018. 64(1): p. 192–200.CrossRefGoogle Scholar
  5. 5.
    Lean, M.E., et al., Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet, 2018. 391(10120): p. 541–551.CrossRefGoogle Scholar
  6. 6.
    Hallberg, S.J., et al., Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study. Diabetes Ther, 2018. 9(2): p. 583–612.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Taylor, R. and A.C. Barnes, Translating aetiological insight into sustainable management of type 2 diabetes. Diabetologia, 2018. 61(2): p. 273–283.CrossRefGoogle Scholar
  8. 8.
    Bhanpuri, N.H., et al., Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study. Cardiovasc Diabetol, 2018. 17(1): p. 56.CrossRefGoogle Scholar
  9. 9.
    Kempf, K., et al., Efficacy of the Telemedical Lifestyle intervention Program TeLiPro in Advanced Stages of Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care, 2017. 40(7): p. 863–871.CrossRefGoogle Scholar
  10. 10.
    Schwarzfuchs, D., R. Golan, and I. Shai, Four-year follow-up after two-year dietary interventions. N Engl J Med, 2012. 367(14): p. 1373–1374.CrossRefGoogle Scholar
  11. 11.
    Shai, I., et al., Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet. The New England Journal of Medicine, 2008. 359(3): p. 229–241.CrossRefGoogle Scholar
  12. 12.
    Krauss, R.M., et al., Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. American Journal of Clinical Nutrition, 2006. 83(5): p. 1025–1031.CrossRefGoogle Scholar
  13. 13.
    Campsall, P., et al., Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study. PLoS Med, 2016. 13(5): p. e1002029.CrossRefGoogle Scholar
  14. 14.
    Norris, S.L., et al., Conflicts of Interest among Authors of Clinical Practice Guidelines for Glycemic Control in Type 2 Diabetes Mellitus. PLoS ONE, 2013. 8(10): p. e75284.CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Rüdesheim amDeutschland

Personalised recommendations